These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 29178362)
1. The relationship between McSorley ST; Khor BY; Tsang K; Colville D; Han S; Horgan PG; McMillan DC Colorectal Dis; 2018 May; 20(5):407-415. PubMed ID: 29178362 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma. Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088 [TBL] [Abstract][Full Text] [Related]
3. Lymph node standardized uptake values at pre-treatment Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891 [TBL] [Abstract][Full Text] [Related]
5. JOURNAL CLUB: Value of Quantitative FDG PET/CT Volumetric Biomarkers in Recurrent Colorectal Cancer Patient Survival. Marcus C; Wray R; Taghipour M; Marashdeh W; Ahn SJ; Mena E; Subramaniam RM AJR Am J Roentgenol; 2016 Aug; 207(2):257-65. PubMed ID: 27447341 [TBL] [Abstract][Full Text] [Related]
6. The relationship between Dolan RD; Maclay JD; Abbass T; Colville D; Buali F; MacLeod N; McSorley ST; Horgan PG; McMillan DC Sci Rep; 2020 Nov; 10(1):20819. PubMed ID: 33257741 [TBL] [Abstract][Full Text] [Related]
7. The significant value of predicting prognosis in patients with colorectal cancer using Xu J; Li Y; Hu S; Lu L; Gao Z; Yuan H Ann Nucl Med; 2019 Jan; 33(1):32-38. PubMed ID: 30218280 [TBL] [Abstract][Full Text] [Related]
8. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma. Satoh K; Patel D; Dieckmann W; Nilubol N; Kebebew E Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of metabolic tumour volume and total lesion glycolysis in Jiménez-Ballvé A; García García-Esquinas M; Salsidua-Arroyo O; Serrano-Palacio A; García-Sáenz JA; Ortega Candil A; Fuentes Ferrer ME; Rodríguez Rey C; Román-Santamaría JM; Moreno F; Carreras-Delgado JL Rev Esp Med Nucl Imagen Mol; 2016; 35(6):365-372. PubMed ID: 26948652 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery. Lee HS; Kim HO; Hong YS; Kim TW; Kim JC; Yu CS; Kim JS J Nucl Med; 2014 Apr; 55(4):582-9. PubMed ID: 24549284 [TBL] [Abstract][Full Text] [Related]
11. Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from Kim YI; Kim YJ; Paeng JC; Cheon GJ; Lee DS; Chung JK; Kang KW Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1787-1795. PubMed ID: 28616695 [TBL] [Abstract][Full Text] [Related]
12. Predictive Value of Metabolic Parameters Derived From Liu H; Ye Z; Yang T; Xie H; Duan T; Li M; Wu M; Song B Front Immunol; 2021; 12():724464. PubMed ID: 34512653 [TBL] [Abstract][Full Text] [Related]
13. Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT. Alongi P; Caobelli F; Gentile R; Stefano A; Russo G; Albano D; Baldari S; Gilardi MC; Midiri M Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):224-233. PubMed ID: 27565154 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer. Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649 [TBL] [Abstract][Full Text] [Related]
15. The value of Oner AO; Budak ES; Yıldırım S; Aydın F; Sezer C Hell J Nucl Med; 2017; 20(2):160-165. PubMed ID: 28697193 [TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of (18)F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site. Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Xuan W; Chicco A; Fowler A Radiother Oncol; 2016 Jul; 120(1):87-91. PubMed ID: 27321151 [TBL] [Abstract][Full Text] [Related]
17. FDG Avidity and Tumor Burden: Survival Outcomes for Patients With Recurrent Breast Cancer. Taghipour M; Wray R; Sheikhbahaei S; Wright JL; Subramaniam RM AJR Am J Roentgenol; 2016 Apr; 206(4):846-55. PubMed ID: 27003053 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma. Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144 [TBL] [Abstract][Full Text] [Related]
20. Consistency of metabolic tumor volume of non-small-cell lung cancer primary tumor measured using 18F-FDG PET/CT at two different tracer uptake times. Liu H; Chen P; Wroblewski K; Hou P; Zhang CP; Jiang Y; Pu Y Nucl Med Commun; 2016 Jan; 37(1):50-6. PubMed ID: 26426969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]